APA (7th ed.) Citation

Chiang, L., Bodzin, A., Lin, D., Hanna, N., Koeneman, S., Dang, H., . . . Zheng, R. (2026). Neoadjuvant Immunotherapy for Hepatocellular Carcinoma Is Associated with Improved Survival After Hepatectomy: A Matched Analysis of the 2017 to 2022 National Cancer Database †. Cancers, 18(13), 2137. https://doi.org/10.3390/cancers18132137

Chicago Style (17th ed.) Citation

Chiang, Lawrence, Adam Bodzin, Daniel Lin, Nader Hanna, Scott Koeneman, Hien Dang, Charles J. Yeo, Christopher Shubert, and Richard Zheng. "Neoadjuvant Immunotherapy for Hepatocellular Carcinoma Is Associated with Improved Survival After Hepatectomy: A Matched Analysis of the 2017 to 2022 National Cancer Database †." Cancers 18, no. 13 (2026): 2137. https://doi.org/10.3390/cancers18132137.

MLA (9th ed.) Citation

Chiang, Lawrence, et al. "Neoadjuvant Immunotherapy for Hepatocellular Carcinoma Is Associated with Improved Survival After Hepatectomy: A Matched Analysis of the 2017 to 2022 National Cancer Database †." Cancers, vol. 18, no. 13, 2026, p. 2137, https://doi.org/10.3390/cancers18132137.